Evidence map›Paper›PMID 40453984›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2025

Identifying Common Diagnostic Biomarkers and Therapeutic Targets between COPD and Sepsis: A Bioinformatics and Machine Learning Approach.

Xinyi Li, Yuyang Xiao, Meng Yang, Xupeng Zhang, Zhangchi Yuan, Zaiqiu Zhang, Hanyong Zhang, Lin Liu, Mingyi Zhao

Abstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xinyi Li *Department of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, People's Republic of China.
Yuyang Xiao *Department of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, People's Republic of China.ORCID 0009-0007-1727-3979
Meng YangDepartment of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, People's Republic of China.ORCID 0009-0002-9330-0274
Xupeng ZhangDepartment of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, People's Republic of China.
Zhangchi YuanDepartment of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, People's Republic of China.
Zaiqiu ZhangDepartment of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, People's Republic of China.
Hanyong ZhangDevelopment of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, 410219, People's Republic of China.
Lin LiuDepartment of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, People's Republic of China.ORCID 0009-0002-7726-0241
Mingyi ZhaoDepartment of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, People's Republic of China.ORCID 0000-0002-2884-0736

Funding

National College Students’ Innovation and Entrepreneurship Training Program NO. X202410533614National Natural Science Foundation of China NO.82102280Natural Scientific Foundation of Hunan Province NO.2022JJ30893Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University NO. YX202212
6 · The paper itself

Abstract

Background: Evidence suggests a bidirectional association between chronic obstructive pulmonary disease (COPD) and sepsis, but the underlying mechanisms remain unclear. This study aimed to explore shared diagnostic genes, potential mechanisms, and the role of immune cells in the COPD-sepsis relationship using Mendelian randomization (MR) and bioinformatics approaches, while also identifying potential therapeutic drugs. Methods: Two-sample MR analysis was performed using genome-wide association data to assess genetically predicted COPD and sepsis. Immune cell-mediated effects were quantified using a two-way two-sample MR analysis. Differential expression gene (DEG) analysis and weighted gene co-expression network analysis (WGCNA) were used to identify common genes. Functional enrichment analyses were conducted to explore the biological roles of these genes. LASSO and SVM-RFE algorithms identified shared diagnostic genes, which were evaluated using receiver operating characteristic (ROC) curves. Immune cell infiltration was analyzed with CIBERSORT, while transcription factor (TF) and miRNA networks were constructed using NetworkAnalyst. Drug predictions were made using DSigDB, and molecular docking validated potential drugs. Results: Three immune cell types were identified as mediators between COPD and sepsis, with genetically predicted effects mediated by these cells at rates of 6.5%, 12.8%, and 3.9%. A total of 33 overlapping genes were identified, and AIM2 and RNF125 were highlighted as key diagnostic genes. Immune infiltration analysis revealed dysregulated monocyte, macrophage, plasma, and dendritic cells. Regulatory network analysis identified nine key co-regulators. Ten potential drug targets were identified, with seven validated via molecular docking. Conclusion: AIM2 and RNF125 may serve as diagnostic biomarkers, and identified immune cell subsets could mediate the COPD-sepsis connection, offering insights into potential therapeutic targets.

Indexed as

Computational BiologyMachine LearningPulmonary Disease, Chronic ObstructiveSepsisBiomarkersGene Expression ProfilingGene Regulatory NetworksGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMendelian Randomization AnalysisMolecular Docking SimulationPredictive Value of TestsBiomarkerschronic obstructive pulmonary diseaseco-diagnostic genescomprehensive bioinformatics analysisimmune cellsmachine learningMendelian randomizationmolecular dockingpredictive drugssepsis

Identifiers

PMID40453984
PMCPMC12126980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.